PMID: 8941774Jun 1, 1996Paper

Susceptibility of biofilms of Streptococcus sanguis to chlorhexidine gluconate and cetylpyridinium chloride

Oral Microbiology and Immunology
M WilsonJ Fletcher

Abstract

Biofilms of Streptococcus sanguis and planktonic cells of the organism were exposed to chlorhexidine gluconate and cetylpyridinium chloride, at concentrations used clinically, and survivors enumerated. S. sanguis exhibited a lower susceptibility to both antiseptics when it comprised a biofilm than when the organism was in the planktonic form. No viable bacteria were detectable after 5 min of exposure of planktonic cells to 0.2% (w/v) chlorhexidine gluconate or 0.05% (w/v) cetylpyridinium chloride, whereas viable bacterial survived in biofilms of S. sanguis even after exposure to these agents for 4 h. Older biofilms (7 days old) had similar susceptibilities to the antiseptics as younger biofilms (4 days old). Chlorhexidine achieved kills corresponding to approximately a 2 log10 reduction in the viable count of biofilms, containing approximately 10(7) colony-forming units after 5 min of incubation, whereas the corresponding kills achieved by cetylpyridinium chloride amounted to approximately a 1 log10 reduction. However, on a molar basis, cetylpyridinium chloride was the more effective of the two antiseptics. Minimum inhibitory concentration determinations showed chlorhexidine gluconate to be more effective against S. sanguis tha...Continue Reading

Citations

Apr 5, 2001·Archives of Oral Biology·T M AuschillN B Artweiler
Nov 1, 2001·Clinical and Diagnostic Laboratory Immunology·Y ShimazakiT Koga
Sep 21, 2005·Journal of Periodontology·M Robert WirthlinCharles I Hoover
Jul 1, 1997·Journal of Periodontal Research·T L WrightM W Mittelman
Sep 4, 2015·Phytotherapy Research : PTR·Tieting ZhangXuedong Zhou
Jun 9, 1999·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·J M SchierholzG Pulverer
Mar 5, 2016·Acta Odontologica Scandinavica·Torgny SjödinMikael Åström
Mar 4, 2008·Acta Biomaterialia·Anne M YoungMichael P Hofmann
Aug 18, 2005·Journal of Periodontal Research·E-M DeckerM Brecx
Apr 8, 2016·Indian Journal of Dental Research : Official Publication of Indian Society for Dental Research·Susanthi RonankiPadma Reddy
Jun 27, 2013·The Journal of Antimicrobial Chemotherapy·William C NanceAlexander H Rickard
Jan 5, 2002·European Journal of Oral Sciences·S BurgemeisterM Brecx
Mar 6, 1998·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·G H Bowden, I R Hamilton
Apr 15, 2015·The Open Dentistry Journal·Per RabeJulia R Davies
Mar 28, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·W XiaA M Young
Apr 17, 2020·European Archives of Paediatric Dentistry : Official Journal of the European Academy of Paediatric Dentistry·A KurtÖ Baygın

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.